Stockscreener 앱 받기
10.96
0.05%
-0.005
시간 외 거래:
10.82
-0.135
-1.23%
전일 마감가:
$10.96
열려 있는:
$11.03
하루 거래량:
25,037
Relative Volume:
0.42
시가총액:
$65.31M
수익:
$100.44M
순이익/손실:
$-133.16M
주가수익비율:
-0.4253
EPS:
-25.76
순현금흐름:
$-94.85M
1주 성능:
-5.15%
1개월 성능:
+18.18%
6개월 성능:
+8.90%
1년 성능:
+42.83%
1일 변동 폭
$10.39
$11.66
1주일 범위
$10.39
$11.84
52주 변동 폭
$5.005
$18.70
아타라 Stock (ATRA) Company Profile
명칭
Atara Biotherapeutics Inc
전화
805-623-4211
주소
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA
ATRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATRA
Atara Biotherapeutics Inc
|
10.96 | 67.87M | 100.44M | -133.16M | -94.85M | -25.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
아타라 Stock (ATRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-11-09 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-11-09 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-07-20 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-07-13 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-05-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-05-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-10 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-30 | 개시 | Evercore ISI | Outperform |
| 2020-06-15 | 개시 | H.C. Wainwright | Buy |
| 2020-04-23 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-11-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-09-27 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-09-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-06-04 | 업그레이드 | Citigroup | Sell → Neutral |
| 2019-05-30 | 개시 | ROTH Capital | Buy |
| 2019-05-23 | 개시 | Stifel | Buy |
| 2019-01-23 | 개시 | Mizuho | Buy |
| 2018-04-10 | 개시 | JP Morgan | Overweight |
| 2018-03-16 | 개시 | Guggenheim | Neutral |
| 2018-03-05 | 재확인 | Jefferies | Buy |
| 2018-02-28 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-02-15 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-01-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2017-10-06 | 재개 | Goldman | Neutral |
모두보기
아타라 주식(ATRA)의 최신 뉴스
Multi asset correlation models including Atara Biotherapeutics Inc.Free Real Time Stock Movement Analysis - Newser
Atara ATRA Q2 2025 Earnings Preview Upside Potential on Strategic Partnerships - AInvest
Atara Biotherapeutics Inc expected to post a loss of 46 cents a shareEarnings Preview - TradingView
Biotech with Heart: Atara’s Path to Hope for MS & Cancer - Tomorrow's World Today
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Is About To Turn The Corner - sg.finance.yahoo.com
What is Atara Biotherapeutics Inc. company’s growth strategyUnlock powerful portfolio management tools - Jammu Links News
What is the risk reward ratio of investing in Atara Biotherapeutics Inc. stockUnlock exclusive trading strategies for gains - Jammu Links News
What are analysts’ price targets for Atara Biotherapeutics Inc. in the next 12 monthsStrong return on investment - Jammu Links News
What are the latest earnings results for Atara Biotherapeutics Inc.Rapid wealth multiplication - Jammu Links News
Does Atara Biotherapeutics Inc. stock perform well during market downturnsHigh-yield trading alerts - Jammu Links News
When is Atara Biotherapeutics Inc. stock expected to show significant growthUnlock powerful portfolio optimization tools - Jammu Links News
What analysts say about Atara Biotherapeutics Inc. stockDiscover stocks with explosive upside potential - Jammu Links News
Should I hold or sell Atara Biotherapeutics Inc. stock in 2025Maximize profits with strategic stock selection - Jammu Links News
What institutional investors are buying Atara Biotherapeutics Inc. stockTriple-digit wealth increases - Jammu Links News
What are Atara Biotherapeutics Inc. company’s key revenue driversGet real-time alerts on top-performing stocks - Jammu Links News
What drives Atara Biotherapeutics Inc. stock priceUnlock daily market insights for better trades - Jammu Links News
What is the dividend policy of Atara Biotherapeutics Inc. stockMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Atara Biotherapeutics Inc. stock higher in 2025Discover high-growth stocks for your portfolio - Jammu Links News
Why is Atara Biotherapeutics Inc. stock attracting strong analyst attentionInvest smarter with data-backed trading alerts - Jammu Links News
Is it the right time to buy Atara Biotherapeutics Inc. stockConsistent high-yield stocks - Jammu Links News
What makes Atara Biotherapeutics Inc. stock price move sharplyNavigate market shifts with confidence - Jammu Links News
FDA Accepts Atara Biotherapeutics’ Resubmission of BLA for Tabelecleucel - CGTLive®
Atara Biotherapeutics Plunges 16.09% Post Reverse Split - AInvest
Atara Biotherapeutics Inc. Stock Lags Behind Sector BenchmarksHigh Accuracy Alerts for ROI Traders Detected - metal.it
Atara Biotherapeutics Inc. Recovery Potential Based on Technical ToolsValue Investing Picks With Stability Outlined - metal.it
Published on: 2025-07-29 09:26:28 - metal.it
Fibonacci Support Holding Strong in Atara Biotherapeutics Inc.Multi-Bagger Potential Stock Forecast Tools Released - metal.it
Published on: 2025-07-28 23:04:32 - metal.it
Is Atara Biotherapeutics Inc. a growth stock or a value stockRapid return acceleration - Jammu Links News
Intrinsic Value of Atara Biotherapeutics Inc. Stock: Is It Undervalued or Overvalued Portfolio Positioning Strategy With Timing - metal.it
What are the technical indicators suggesting about Atara Biotherapeutics Inc.Build wealth faster with disciplined trading - Jammu Links News
How Atara Biotherapeutics Inc. stock performs during market volatilityHigh Accuracy Alerts - Newser
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Rocket Pharmaceuticals (RCKT) and Atara Biotherapeutics (ATRA) - The Globe and Mail
Atara Biotherapeutics stock jumps after FDA accepts BLA for tab-cel - Investing.com India
아타라 (ATRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):